Search

Start Over Subject medicine

12. The long-term effects of growth hormone replacement on bone mineral density and trabecular bone score: results of the 10-year prospective follow-up

Creator:
Vaňuga, Peter, Kužma, Martin, Stojkovičová, Dáša, Smaha, Juraj, Jackuliak, Peter, Killinger, Zdenko, and Payer, Juraj
Format:
počítač and online zdroj
Type:
model:article and TEXT
Subject:
fyziologie člověka, lékařství, human physiology, medicine, Growth hormone, IGF-1, Bone mineral density, Trabecular bone score, 14, and 612
Language:
English
Description:
There are only few studies concerning about long-term effect of growth hormone (GH) replacement therapy on bone mineral density and bone microstructure. To assess effect of GH replacement therapy on bone mineral density (BMD) and trabecular bone score (TBS) in adult GH deficient (AGHD) subjects over period of 10 years. From 2005 to 2018, a prospective study of AGHD patients was conducted in national referral center for treatment of GHD. All patients received subcutaneous recombinant human GH in an IGF-1-normalizing regimen once a day. Lumbar spine (L-spine) and total hip (TH) BMD using Hologic densitometers were measured at baseline and every two years during treatment with rhGH. TBS was derived from L1-L4 DXA using iNsight® software (Medimaps, France) at each time point. Periods of measurement were baseline, year 2; 4; 6; 8 and 10. In total, 63 patients (38 males, 25 females, mean age 25.1±16 years) were included in the study. After 10 years of GH treatment, IGF-1 significantly increased (~35 %), with greatest increase at year 2. During 10-year follow-up, L-spine BMD increased approximately of 7 % (NS). TH BMD increase of 11 % during follow-up (p=0.0003). The greatest increment of BMD was achieved at year 6 on both sites, L-spine (+6 %) and TH BMD (+13 %) (p<0.05). There was no significant change of TBS during whole follow-up. In this study, sustaining positive effect of GH replacement therapy on bone density in subjects with adult GH deficiency over 10 years of follow-up was observed. The study did not show effect on TBS, as indirect measure of trabecular bone microarchitecture., Peter Vaňuga, Martin Kužma, Dáša Stojkovičová, Juraj Smaha, Peter Jackuliak, Zdenko Killinger, Juraj Payer., and Obsahuje bibliografii
Rights:
http://creativecommons.org/licenses/by-nc-sa/4.0/ and policy:public

13. The severity of muscle performance deterioration in sarcopenia correlates with circulating muscle tissue-specific miRNAs

Creator:
Valášková, Simona, Gažová, Andrea, Vrbová, Petra, Koller, Tomáš, Šalingová, Barbara, Adamičková, Adriana, Chomaničová, Nikola, Hulajová, Nikoleta, Payer, Juraj, and Kyselovič, Ján
Format:
počítač and online zdroj
Type:
model:article and TEXT
Subject:
fyziologie člověka, lékařství, human physiology, medicine, Sarcopenia, MiRNAs, Biomarker, 14, and 612
Language:
English
Description:
a1_Sarcopenia is defined as an age-associated loss of skeletal muscle function and muscle mass and is common in older adults. Sarcopenia as a disease is currently of interest not only to orthopedists and surgeons but also to internists, endocrinologists, rheumatologists, cardiologists, diabetologists, gynaecologists, geriatricians and paediatricians. In cooperation with the 5th Internal Medicine Clinic, we, as a unit of clinical research, aimed to describe a sarcopenic specific miRNA expression profile for disease diagnostics and classification of the severity of muscle performance deterioration. This study included a total of 80 patients (age 55-86 years) hospitalized at the V. Internal medicine clinic of LFUK and UNB with different severity of muscle performance deterioration. The study participants were evaluated and classified according to short physical performance battery score (SPPB). In this study, we investigated the role of circulating miRNAs in sarcopenia in the elderly. We hypothesized that sarcopenia effects the expression of muscle tissue-specific miRNAs (MyomiRNAs), which could be potentially reflected in the blood plasma miRNA expression profile. The expression of specific circulating miRNAs in patients with different muscle performances was analyzed. Patients’ blood plasma was evaluated for the expression of myomiRNAs: miRNA-29a, miRNA-29b, miRNA-1, miRNA-133a, miRNA-133b, miRNA-206, miRNA-208b and miRNA-499, and the data were correlated with diagnostic indicators of the disease. We showed a specific sarcopenia miRNA profile that could be considered a possible biomarker for the disease. Patients with low muscle performance showed increased miRNA-1, miRNA-29a and miRNA-29b expression and decreased for the miRNA-206, miRNA-133a, miRNA-133b, miRNA-208b and miRNA-499 expression., a2_ We show that the severity of muscle performance deterioration in sarcopenia correlates with specific miRNA expression. We also propose the profile of miRNAs expression in blood plasma as a specific biomarker for sarcopenia diagnostics. Future clinical studies will be necessary to eventually naturally have to elucidate the underlined molecular mechanism responsible for specific miRNAs expression in sarcopenia pathology and progression of the disease., Simona Valášková, Andrea Gažová, Petra Vrbová, Tomáš Koller, Barbara Šalingova, Adriana Adamičková, Nikola Chomaničová, Nikoleta Hulajová, Juraj Payer, Ján Kyselovič., and Obsahuje bibliografii
Rights:
http://creativecommons.org/licenses/by-nc-sa/4.0/ and policy:public

14. Treatment with cholecalciferol leads to increase of selected semen parameters in young infertile males: results of a 6-month interventional study

Creator:
Bartl, Igor, Ondrušová, Miroslava, Kužma, Martin, Jackuliak, Peter, Gažová, Andrea, Kyselovič, Ján, and Payer, Juraj
Format:
počítač and online zdroj
Type:
model:article and TEXT
Subject:
fyziologie člověka, lékařství, vitamin D, human physiology, medicine, Vitamin D receptor, Infertility, Male health, 14, and 612
Language:
English
Description:
High incidence of infertility along with low vitamin D levels was detected in otherwise healthy young men. The aim is to observe the effect of vitamin D supplementation on semen parameters as assessed by semen analysis in infertile men. In total, 45 men (mean age 36.6 years) in consecutive order were included, of whom 34 finished the study. Subjects were supplemented by vitamin D (cholecalciferol) 2500 IU/day. Vitamin D levels were assessed by HPLC. Semen analysis was performed strictly following 2010 WHO guidelines. Study periods were baseline and month 6. During follow-up, 20 %, 7.4 %, 22 % and 0.7 % increase in serum vitamin D levels, progressive sperm motility, sperm concentration and sperm morphology, respectively, were observed (all p<0.05). At follow-up end, 9 patients (26 %) reached normal sperm parameters of whom 2 fertilized their partner. There was no correlation between vitamin D and semen parameters observed. This study proves that vitamin D supplementation is possibly a modulator of sperm parameters in vitamin D deficient, otherwise healthy men. Although a direct relationship between vitamin D and sperm parameters was not observed obtaining adequate vitamin D levels could likely play a role in the male factor of infertility., Igor Bartl, Miroslava Ondrušová, Martin Kužma, Peter Jackuliak, Andrea Gažová, Ján Kyselovič, Juraj Payer., and Obsahuje bibliografii
Rights:
http://creativecommons.org/licenses/by-nc-sa/4.0/ and policy:public

15. Umělý člověk

Creator:
Černoch, Viktor and Adamková, Gabriela
Format:
print, text, regular print, bez média, and svazek
Type:
article, články, journal articles, model:article, and TEXT
Subject:
Věda. Všeobecnosti. Základy vědy a kultury. Vědecká práce, věda, lékařství, androidi, science, medicine, 12, and 00
Language:
Czech
Description:
Ještěrky dokážou v nouzi odhodit svůj ocas a ten jim naroste. Axolotl mexický je schopen regenerovat celé orgány. Přeborníky jsou však ploštěnci - nejen že libovolné části jejich těl dorůstají, ale z odděleného kousku jejich organismu dokáže vyrůst celý nový jedinec. Takové regegnerační schopnosti lidský organismus nemá. Věda a medicína ale umí nahradit, či dokonce vylepšit stále více a více... and VIktor Černoch, Gabriela Adamková.
Rights:
http://creativecommons.org/licenses/by-nc-sa/4.0/ and policy:public